Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2013. The report was filed on October 11, 2013, and primarily addresses corporate governance updates rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate announcement and does not contain financial statements.
Material Changes
The only material change disclosed is a personnel appointment within the Board of Directors. Hans Wijers, a Non-Executive Director, was appointed as a member of the Corporate Responsibility and Remuneration Committees effective October 10, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly an announcement of board committee changes.
Key Facts for Investors
- Hans Wijers joined the Corporate Responsibility and Remuneration Committees on October 10, 2013.
- This filing does not include financial results or forward-looking statements.
- The report was signed by Simon Bicknell, the Company Secretary.